INM (InMed Pharmaceuticals Inc. Common Shares) Stock Analysis - Politician Trades

InMed Pharmaceuticals Inc. Common Shares (INM) is a publicly traded Healthcare sector company. As of May 19, 2026, INM trades at $1.42 with a market cap of $2.12M and a P/E ratio of -0.08. INM moved +125.50% today. Year to date, INM is -39.22%; over the trailing twelve months it is -76.93%. Its 52-week range spans $0.58 to $8.27. Rallies surfaces INM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded INM stock?

Rallies tracks politician and congressional stock disclosures for INM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

INM Key Metrics

Key financial metrics for INM
MetricValue
Price$1.42
Market Cap$2.12M
P/E Ratio-0.08
EPS$-8.36
Dividend Yield0.00%
52-Week High$8.27
52-Week Low$0.58
Volume70.34M
Avg Volume0
Revenue (TTM)$4.94M
Net Income$-8.16M
Gross Margin34.53%

Latest INM News

Recent INM Insider Trades

  • MANCINI ALEXANDRA DIANE JANET sold 240 (~$42.312) on Jul 31, 2024.
  • HULL ANDREW bought 37.50K (~$14.63K) on Feb 21, 2024.
  • ADAMS ERIC A bought 41.60K (~$14.92K) on Feb 20, 2024.

INM Analyst Consensus

INM analyst coverage data. Average price target: $0.00.

Common questions about INM

Which politicians traded INM stock?
Rallies tracks politician and congressional stock disclosures for INM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in INM?
Yes. Rallies tracks politician and congressional stock disclosures for INM, including reported purchases, sales, dates, owners, and trade amounts when available.
Is INM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for INM. It does not provide personalized investment advice.
INM

INM